Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengmei Yuan

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Affective Disorders|May 19, 2015
Guidelines concordance of maintenance treatment in euthymic patients with bipolar disorder: Data from the national bipolar mania pathway survey (BIPAS) in mainland ChinaZuowei Wang, Jun Chen, Chen Zhang, et al.
Journal of Affective Disorders|September 23, 2014
Validation of the Chinese Version of the Short TEMPS-A and its application in patients with mood disordersChengmei Yuan, Jia Huang, Keming Gao, et al.
Plos One|April 26, 2014
Guidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland ChinaZuowei Wang, Keming Gao, Wu Hong, et al.
Sleep Medicine|December 24, 2025
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorderWei-Feng Mi, Dan Wen, Lijun Xu, et al.
International Journal of Clinical and Health Psychology : IJCHP|April 18, 2025
Exploring the associations between data-driven insomnia disorder combined with mild anxiety or/and depressive symptoms and the efficacy of Cognitive-Behavioral Therapy for insomniaDongbin Lyu, Ruiyi Qian, Fangmei Ge, et al.
Journal of Psychiatric Research|November 10, 2012
The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practiceZezhi Li, Yanxia Zhang, Zuowei Wang, et al.
Psychoneuroendocrinology|April 26, 2017
Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: Result from a prospective longitudinal studyZezhi Li, Zuowei Wang, Chen Zhang, et al.
Journal of Affective Disorders|May 21, 2018
Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depressionRuizhi Mao, Chen Zhang, Jun Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2021
Neural biomarker of functional disability in major depressive disorder: A structural neuroimaging studyRubai Zhou, Jun Chen, Guoqing Zhao, et al.
Sleep|June 25, 2025
Efficacy and Safety of Daridorexant in Chinese Patients with Insomnia Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical TrialZhaoyang Huang, Hanqiao Wang, Bin Zhang, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Affective Disorders|May 19, 2015
Guidelines concordance of maintenance treatment in euthymic patients with bipolar disorder: Data from the national bipolar mania pathway survey (BIPAS) in mainland ChinaZuowei Wang, Jun Chen, Chen Zhang, et al.
Journal of Affective Disorders|September 23, 2014
Validation of the Chinese Version of the Short TEMPS-A and its application in patients with mood disordersChengmei Yuan, Jia Huang, Keming Gao, et al.
Plos One|April 26, 2014
Guidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland ChinaZuowei Wang, Keming Gao, Wu Hong, et al.
Sleep Medicine|December 24, 2025
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorderWei-Feng Mi, Dan Wen, Lijun Xu, et al.
International Journal of Clinical and Health Psychology : IJCHP|April 18, 2025
Exploring the associations between data-driven insomnia disorder combined with mild anxiety or/and depressive symptoms and the efficacy of Cognitive-Behavioral Therapy for insomniaDongbin Lyu, Ruiyi Qian, Fangmei Ge, et al.
Journal of Psychiatric Research|November 10, 2012
The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practiceZezhi Li, Yanxia Zhang, Zuowei Wang, et al.
Psychoneuroendocrinology|April 26, 2017
Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: Result from a prospective longitudinal studyZezhi Li, Zuowei Wang, Chen Zhang, et al.
Journal of Affective Disorders|May 21, 2018
Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depressionRuizhi Mao, Chen Zhang, Jun Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2021
Neural biomarker of functional disability in major depressive disorder: A structural neuroimaging studyRubai Zhou, Jun Chen, Guoqing Zhao, et al.
Sleep|June 25, 2025
Efficacy and Safety of Daridorexant in Chinese Patients with Insomnia Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical TrialZhaoyang Huang, Hanqiao Wang, Bin Zhang, et al.
Pageof 5